FDA Floats Plan To Streamline New Drug Trials
In the finalized guidance, the FDA outlined how corporations and organizations can propose and win agency backing for so-called drug development tools that can be used in different studies to evaluate a drug.
Tools can take many forms. There are so-called biomarkers that may...
To view the full article, register now.